Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11.
Saved in:
| Title: | Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. |
|---|---|
| Authors: | Bertuccioli A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy., Sisti D; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy., Lazzerini N; USL Tuscany South-East Company, Valdarno Hospital 'La Gruccia', U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit, Montevarchi, Italy., Palazzi CM; Microbiota International Clinical Society, Torino, Italy., Zonzini GB; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.; Microbiota International Clinical Society, Torino, Italy., Ragazzini M; Microbiota International Clinical Society, Torino, Italy., Belli A; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2025 May 20; Vol. 12, pp. 1604319. Date of Electronic Publication: 2025 May 20 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2025.1604319 |
